NCT03073018View on ClinicalTrials.gov

Prevention of Renal and Vascular Endstage Disease Intervention Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

864

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

June 30, 2003

Study Completion Date

November 30, 2003

Conditions
MicroalbuminuriaCardiovascular DiseasesRenal Disease
Interventions
DRUG

Fosinopril

oral administration, capsules

DRUG

Pravastatin

oral administration, capsules

DRUG

Fosinopril Placebo

oral administration, capsules

DRUG

Pravastatin Placebo

oral administration, capsules

All Listed Sponsors
collaborator

Dutch Kidney Foundation

OTHER

collaborator

Netherlands Heart Foundation

OTHER

lead

University Medical Center Groningen

OTHER

NCT03073018 - Prevention of Renal and Vascular Endstage Disease Intervention Trial | Biotech Hunter | Biotech Hunter